Skip to main navigation Skip to search Skip to main content

IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction

  • Jillian L. Barlow (Lead / Corresponding author)
  • , Samantha Peel
  • , Jane Fox
  • , Veera Panova
  • , Clare S. Hardman
  • , Ana Camelo
  • , Christine M. Bucks
  • , Xiaoying Wu
  • , Colleen M. Kane
  • , Daniel Neill
  • , Robin J. Flynn
  • , Ian Sayers
  • , Ian P. Hall
  • , Andrew N. J. McKenzie

Research output: Contribution to journal › Article › peer-review

Abstract

Background: IL-25 and IL-33 belong to distinct cytokine families, but experimental mouse studies suggest their immunologic functions in type 2 immunity are almost entirely overlapping. However, only polymorphisms in the IL-33 pathway (IL1RL1 and IL33) have been significantly associated with asthma in large-cohort genome-wide association studies.
Objective: We sought to identify distinct pathways for IL-25 and IL-33 in the lung that might provide insight into their roles in asthma pathogenesis and potential for therapeutic intervention.
Methods: IL-25 receptor–deficient (Il17rb-/-), IL-33 receptor– deficient (ST2, Il1rl1-/-), and double-deficient (Il17rb-/-/2Il1rl1-/-) mice were analyzed in models of allergic asthma. Microarrays, an ex vivo lung slice airway contraction model, and Il131+/eGFP mice were then used to identify specific effects of IL-25 and IL-33 administration.
Results: Comparison of IL-25 and IL-33 pathway–deficient mice demonstrates that IL-33 signaling plays a more important in vivo role in airways hyperreactivity than IL-25. Furthermore, methacholine-induced airway contraction ex vivo increases after treatment with IL-33 but not IL-25. This is dependent on expression of the IL-33 receptor and type 2 cytokines. Confocal studies with Il131+/eGFP mice show that IL-33 more potently induces expansion of IL-13–producing type 2 innate lymphoid cells, correlating with airway contraction. This predominance of IL-33 activity is enforced in vivo because IL-33 is more rapidly expressed and released in comparison with IL-25.
Conclusion: Our data demonstrate that IL-33 plays a critical role in the rapid induction of airway contraction by stimulating the prompt expansion of IL-13–producing type 2 innate lymphoid cells, whereas IL-25–induced responses are slower and less potent. 
Original languageEnglish
Pages (from-to)933-941
Number of pages9
JournalJournal of Allergy and Clinical Immunology
Volume132
Issue number4
DOIs
Publication statusPublished - Oct 2013

Keywords

  • Animals
  • Asthma/immunology
  • Bronchial Hyperreactivity/immunology
  • Humans
  • Interleukin-13/biosynthesis
  • Interleukin-33
  • Interleukins/immunology
  • Lung/immunology
  • Lymphocytes/immunology
  • Mice
  • Mice, Inbred BALB C
  • Th2 Cells/cytology

Fingerprint

Dive into the research topics of 'IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction'. Together they form a unique fingerprint.

Cite this